BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 2467734)

  • 21. Endodermal sinus tumor in children.
    Davidoff AM; Hebra A; Bunin N; Shochat SJ; Schnaufer L
    J Pediatr Surg; 1996 Aug; 31(8):1075-8; discussion 1078-9. PubMed ID: 8863237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
    Billmire DF; Cullen JW; Rescorla FJ; Davis M; Schlatter MG; Olson TA; Malogolowkin MH; Pashankar F; Villaluna D; Krailo M; Egler RA; Rodriguez-Galindo C; Frazier AL
    J Clin Oncol; 2014 Feb; 32(5):465-70. PubMed ID: 24395845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current optimum management of anaplastic germ cell tumours of the testis and other sites.
    Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Crawford SM; Holden L
    Br J Urol; 1986 Jun; 58(3):307-14. PubMed ID: 2424538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
    Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
    Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy of extragonadal germ cell tumors.
    Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
    Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
    Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
    Fizazi K; Do KA; Wang X; Finn L; Logothetis CJ; Amato RJ
    Ann Oncol; 2002 Jan; 13(1):125-34. PubMed ID: 11863094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
    Price P; Hogan SJ; Bliss JM; Horwich A
    Eur J Cancer; 1990 Apr; 26(4):453-7. PubMed ID: 1694087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Testicular malignant tumours. Efficacy of germ cell and sex cord tumours treatment protocol in Poland].
    Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):811-7. PubMed ID: 17317912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment of germ cell tumors of the ovary].
    Sawada M; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2489-95. PubMed ID: 6210050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
    Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG
    Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
    Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
    J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours.
    Horwich A; Brada M; Nicholls J; Jay G; Hendry WF; Dearnaley D; Peckham MJ
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):177-84. PubMed ID: 2467806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
    Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of nonseminomatous testicular germ cell tumors].
    Nukui M; Nakao M; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maekawa M
    Hinyokika Kiyo; 1991 Oct; 37(10):1281-5. PubMed ID: 1721771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 study.
    Pavone R; Pacquement H; Pasquet M; Sudour-Bonnange H; Hameury F; Sarnacki S; Chastagner P; Faure-Conter C; Poirée M; Taque S; Patte C; Fresneau B
    Int J Cancer; 2021 Nov; 149(9):1705-1712. PubMed ID: 34146403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors.
    Carter GE; Lieskovsky G; Skinner DG; Daniels JR
    J Urol; 1987 Dec; 138(6):1397-401. PubMed ID: 2446018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG).
    Malogolowkin MH; Krailo M; Marina N; Olson T; Frazier AL
    Pediatr Blood Cancer; 2013 Oct; 60(10):1602-5. PubMed ID: 23703725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group.
    Mann JR; Raafat F; Robinson K; Imeson J; Gornall P; Phillips M; Sokal M; Gray E; McKeever P; Oakhill A
    Med Pediatr Oncol; 1998 Apr; 30(4):217-27. PubMed ID: 9473756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.